Related references
Note: Only part of the references are listed.Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
R. Ruiter et al.
DIABETOLOGIA (2012)
The Metabolic Syndrome and Risk of Prostate Cancer in Italy
Claudio Pelucchi et al.
ANNALS OF EPIDEMIOLOGY (2011)
Targeting the insulin-like growth factor network in cancer therapy
Isabel Heidegger et al.
CANCER BIOLOGY & THERAPY (2011)
Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case-Control Study in Denmark
Jaclyn Lee Fong Bosco et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Long-term effects of insulin glargine on the risk of breast cancer
S. Suissa et al.
DIABETOLOGIA (2011)
The uncertain relationship between obesity and prostate cancer: An Italian biopsy cohort analysis
C. De Nunzio et al.
EJSO (2011)
Insulin receptor and cancer
Antonino Belfiore et al.
ENDOCRINE-RELATED CANCER (2011)
Minireview: IGF, Insulin, and Cancer
Emily J. Gallagher et al.
ENDOCRINOLOGY (2011)
Enzymatic features of the glucose metabolism in tumor cells
Anique Herling et al.
FEBS JOURNAL (2011)
Associations between adipokines and obesity-related cancer
Gilberto Paz-Filho et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis
Hiroki Endo et al.
GUT (2011)
Diabetes and prognosis in a breast cancer cohort
Michael G. Schrauder et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
R. Rattan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Clinically Defined Type 2 Diabetes Mellitus and Prognosis in Early-Stage Breast Cancer
Kirsten Erickson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
Kimberly S. Peairs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Diabetes Mellitus, Race and the Odds of High Grade Prostate Cancer in Men Treated With Radiation Therapy
Timur Mitin et al.
JOURNAL OF UROLOGY (2011)
Research Resource: New and Diverse Substrates for the Insulin Receptor Isoform A Revealed by Quantitative Proteomics After Stimulation With IGF-II or Insulin
Alaide Morcavallo et al.
MOLECULAR ENDOCRINOLOGY (2011)
Targeting cancer metabolism: a therapeutic window opens
Matthew G. Vander Heiden
NATURE REVIEWS DRUG DISCOVERY (2011)
Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer
Spyros P. Gialamas et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Mechanisms of Disease: Hypoxia and Inflammation.
Holger K. Eltzschig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Diabetes and prostate cancer risk in the REDUCE trial
C. Wu et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study
Shelley S. Tworoger et al.
BREAST CANCER RESEARCH (2011)
Transcriptional and post-translational regulation of adiponectin
Meilian Liu et al.
BIOCHEMICAL JOURNAL (2010)
Evidence for a tumor promoting effect of high-fat diet independent of insulin resistance in HER2/Neu mammary carcinogenesis
Sarah Khalid et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Medical comorbidities predict mortality in women with a history of early stage breast cancer
Ruth E. Patterson et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes
Ruslan Novosyadlyy et al.
CANCER RESEARCH (2010)
Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes-Mediated Mammary Tumor Progression
Yvonne Fierz et al.
DIABETES (2010)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes - ZODIAC-16
Gijs W. D. Landman et al.
DIABETES CARE (2010)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
THE PATHWAY FROM DIABETES AND OBESITY TO CANCER, ON THE ROUTE TO TARGETED THERAPY
Emily J. Gallagher et al.
ENDOCRINE PRACTICE (2010)
Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes
Yvonne Fierz et al.
ENDOCRINE-RELATED CANCER (2010)
Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy
Leigh A. Cantrell et al.
GYNECOLOGIC ONCOLOGY (2010)
Insulin-Like Growth Factor-I and Cancer Mortality in Older Men
Jacqueline M. Major et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A Fully Human Insulin-Like Growth Factor-I Receptor Antibody SCH 717454 (Robatumumab) Has Antitumor Activity as a Single Agent and in Combination with Cytotoxics in Pediatric Tumor Xenografts
Yaolin Wang et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Ligand-Specific Antibodies to Insulin-Like Growth Factors Suppress Intestinal Polyp Formation in Apc+/- Mice
Toshihiro Matsunaka et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
Issam Ben Sahra et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival
D. Sachdev et al.
ONCOGENE (2010)
Metastasis suppression by adiponectin LKB1 rises up to the challenge
Neeraj K. Saxena et al.
CELL ADHESION & MIGRATION (2010)
Green Tea Catechin Controls Apoptosis in Colon Cancer Cells by Attenuation of H2O2-Stimulated COX-2 Expression via the AMPK Signaling Pathway at Low-Dose H2O2
In-Ja Park et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Is it Time to Test Metformin in Breast Cancer Clinical Trials?
Massimiliano Cazzaniga et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Adiponectin-Activated AMPK Stimulates Dephosphorylation of AKT through Protein Phosphatase 2A Activation
Kun-yong Kim et al.
CANCER RESEARCH (2009)
Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
Krisztina Kisfalvi et al.
CANCER RESEARCH (2009)
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
Irina N. Alimova et al.
CELL CYCLE (2009)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
Adipose Tissue: The New Endocrine Organ? A Review Article
Susan E. Wozniak et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Obesity and Breast Cancer: The Estrogen Connection
Margot P. Cleary et al.
ENDOCRINOLOGY (2009)
Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies
Wensen Chen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Marc J. Gunter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Joan M. Carboni et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells
J. Zhou et al.
ONCOGENE (2009)
The Protective Effect of Diabetes Mellitus Against Prostate Cancer: Role of Sex Hormones
N. Baradaran et al.
PROSTATE (2009)
Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database
S. J. Freedland et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2009)
A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer
Marc J. Gunter et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women
Marc J. Gunter et al.
CANCER RESEARCH (2008)
Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model
Naoko Kobayashi et al.
CANCER RESEARCH (2008)
Serum prostate-specific antigen levels in men with type 2 diabetes
Michiaki Fiukui et al.
DIABETES CARE (2008)
Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2008)
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis
Bethany B. Barone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Low testosterone levels are common and associated with insulin resistance in men with diabetes
Mathis Grossmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 receptor monoclonal antibody CP-751,871 in patients with multiple myeloma
Martha Q. Lacy et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
Jing Ma et al.
LANCET ONCOLOGY (2008)
Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones
Nomeli P. Nunez et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Obesity Is a Significant Risk Factor for Prostate Cancer at the Time of Biopsy
Stephen J. Freedland et al.
UROLOGY (2008)
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Francesco Frasca et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Effect of adiponectin and ghrelin on apoptosis of barrett adenocarcinoma cell line
Peter C. Konturek et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts
Vasundara Venkateswaran et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
Gillian K. Reeves et al.
BRITISH MEDICAL JOURNAL (2007)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Phase I dose escalation study of the anti-insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors
Paul Haluska et al.
CLINICAL CANCER RESEARCH (2007)
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer
David R. Clemmons
NATURE REVIEWS DRUG DISCOVERY (2007)
IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells
C. M. Perks et al.
ONCOGENE (2007)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition
Mazda Jenab et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Insulin resistance is inversely related to prostate cancer: A prospective study in Northern Sweden
Tanja Stocks et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231
Francesco Turturro et al.
BMC CANCER (2007)
Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue -: Mechanism for growth hormone-mediated insulin resistance
Juan-Pablo del Rincon et al.
DIABETES (2007)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women
Anne E. Cust et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002
David M. Werny et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Novel insulin analogues and its mitogenic potential
Ivana Zib et al.
DIABETES OBESITY & METABOLISM (2006)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Jocelyn S. Kasper et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Stress and mTORture signaling
J. H. Reiling et al.
ONCOGENE (2006)
Adipose tissue as an endocrine organ
Rexford S. Ahima
OBESITY (2006)
Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation
Nomeli P. Nunez et al.
CANCER RESEARCH (2006)
Adiponectin and cancer: a systematic review
I Kelesidis et al.
BRITISH JOURNAL OF CANCER (2006)
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria
K Rapp et al.
DIABETOLOGIA (2006)
Tumour necrosis factor-α as a tumour promoter
P Szlosarek et al.
EUROPEAN JOURNAL OF CANCER (2006)
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation
B Guigas et al.
DIABETES (2006)
Adiponectin as a growth inhibitor in prostate cancer cells
JD Bub et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways
AJ Levine et al.
GENES & DEVELOPMENT (2006)
In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417
P Haluska et al.
CANCER RESEARCH (2006)
Postmenopausal serum androgens, oestrogens and breast cancer risk:: the European prospective investigation into cancer and nutrition
R Kaaks et al.
ENDOCRINE-RELATED CANCER (2005)
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
SC Larsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models
S Yakar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice
VN Anisimov et al.
EXPERIMENTAL GERONTOLOGY (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Fasting serum glucose level and cancer risk in Korean men and women
SH Jee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats
R Hakkak et al.
BREAST CANCER RESEARCH (2005)
Obesity and risk of cancer in Japan
S Kuriyama et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
A prospective study of plasma C-peptide and colorectal cancer risk in men
J Ma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Adiponectin and breast cancer risk
C Mantzoros et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis
E Bråkenhielm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Association of obesity and cancer risk in Canada
SY Pan et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy
CL Amling et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Adipokines: inflammation and the pleiotropic role of white adipose tissue
P Trayhurn et al.
BRITISH JOURNAL OF NUTRITION (2004)
Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors
M Goya et al.
CANCER RESEARCH (2004)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study
A Zeleniuch-Jacquotte et al.
BRITISH JOURNAL OF CANCER (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Diet-induced obesity and mammary tumor development in MMTV-neu female mice
MP Cleary et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
Prostate cancer cell proliferation is influenced by leptin
P Somasundar et al.
JOURNAL OF SURGICAL RESEARCH (2004)
Insulin-like growth factor-II regulates PTEN expression in the mammary gland
RA Moorehead et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Prostate cancer cell-adipocyte interaction -: Leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase
M Onuma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The insulin-like growth factor system and cancer
D LeRoith et al.
CANCER LETTERS (2003)
Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study
KB Michels et al.
DIABETES CARE (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Mortality from site-specific malignancies in type 2 diabetic patients from Verona
G Verlato et al.
DIABETES CARE (2003)
Genetically obese MMTV-TGF-α/LepobLepob female mice do not develop mammary tumors
MP Cleary et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A
L Sciacca et al.
ONCOGENE (2002)
Hypoxia-inducible factor 1 transactivates the human leptin gene promoter
A Grosfeld et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
No effect of a high-fat diet on promotion of sex hormone-induced prostate and mammary carcinogenesis in the Noble rat model
G Leung et al.
BRITISH JOURNAL OF NUTRITION (2002)
Transcriptional activation of the human leptin gene in response to hypoxia - Involvement of hypoxia-inducible factor 1
G Ambrosini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Leptin mediates a proliferative response in human MCF7 breast cancer cells
MN Dieudonne et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Modulation by leptin of proliferation and apoptosis in vascular endothelial cells
M Artwohl et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer
V Vella et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Potential role of leptin in angiogenesis:: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro
HY Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2001)
Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF
RH Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older
R Yancik et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
R Kaaks et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2001)
Hypoxia and oxidative stress in breast cancer - Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer
NS Brown et al.
BREAST CANCER RESEARCH (2001)
Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue
PG McTernan et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Hormonal predictors of prostate cancer: A meta-analysis
T Shaneyfelt et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
